Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$272.69
▼ $6.01 (−2.16%) today
Markets closed · 5:33pm ET

JNJ Coverage Page 47

11:18am ET
Health and Healthcare

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes

Johnson & Johnson has announced that it will accelerate initiation of its early stage first-in-human clinical trial for the treatment of COVID-19. Shares got a mild boost on Wednesday from the news.

JNJ
Chris Lange